CDC Emphasizes Opioid Guideline is Voluntary and Should Support, Not Supplant, Patient Care
The FDA Law Blog
NOVEMBER 29, 2022
In addition, the guideline has been misapplied to cancer and palliative care patients, and there have been rapid opioid tapers without patient collaboration, rigid application of opioid dosage thresholds, application of opioid use for pain to opioid use disorder treatment, insurer and pharmacy duration limits, patient dismissals and abandonment.
Let's personalize your content